ESAB Q1 2025 diluted EPS rises to $1.10 as sales fall 2% to $678 million
ESAB reported first-quarter 2025 sales of $678 million, down 2% on a reported basis and flat on a core organic basis, while net income attributable to ESAB rose to $67.4 million, or $1.10 per diluted share, from $0.98 a year earlier. The company raised its full-year 2025 core sales growth outlook to (1.0)% to 1.5% and its core adjusted EBITDA outlook to $520 million to $530 million, and kept core adjusted EPS guidance at $5.10 to $5.25.
Key points
- Q1 2025 sales were $678 million, down 2% reported and flat on a core organic basis; core adjusted EBITDA was $128 million, up 4%, with margin up 100 basis points to 19.8%
- Diluted EPS was $1.10 on net income attributable to ESAB of $67.4 million; core adjusted diluted EPS was $1.25, compared with $1.20 a year earlier
- Full-year 2025 core sales growth outlook raised to (1.0)% to 1.5% from (2.0)% to 0.0%; core adjusted EBITDA outlook raised to $520 million to $530 million from $515 million to $530 million
- ESAB completed its acquisition of Bavaria Schweisstechnik GmbH on April 30, 2025
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 01, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.